Ambu A/S (CO:AMBU-B) — Market Cap & Net Worth
Market Cap & Net Worth: Ambu A/S (AMBU-B)
Ambu A/S (CO:AMBU-B) has a market capitalization of $2.39 Billion (Dkr15.26 Billion) as of September 16, 2026. Listed on the CO stock exchange, this Denmark-based company holds position #5593 globally and #34 in its home market, demonstrating a -1.10% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ambu A/S's stock price Dkr67.30 by its total outstanding shares 226726039 (226.73 Million). Also see AMBU-B total assets for a full breakdown of the balance sheet.
Ambu A/S Market Cap History: 2015 to 2026
Ambu A/S's market capitalization history from 2015 to 2026. Data shows growth from $1.46 Billion to $2.35 Billion (5.18% CAGR). Also see Ambu A/S cash flow conversion for how efficiently the company converts equity into cash flow.
Ambu A/S Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ambu A/S's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check today's stock price for Ambu A/S for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.52x
Ambu A/S's market cap is 0.52 times its annual revenue
Latest Price to Earnings (P/E) Ratio
5.13x
Ambu A/S's market cap is 5.13 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.99 Billion | $2.08 Billion | $250.00 Million | 0.95x | 7.94x |
| 2017 | $3.91 Billion | $2.35 Billion | $301.00 Million | 1.66x | 12.98x |
| 2018 | $5.52 Billion | $2.61 Billion | $337.00 Million | 2.12x | 16.38x |
| 2019 | $3.95 Billion | $2.82 Billion | $317.00 Million | 1.40x | 12.46x |
| 2020 | $9.32 Billion | $3.57 Billion | $241.00 Million | 2.61x | 38.67x |
| 2021 | $6.14 Billion | $4.01 Billion | $247.00 Million | 1.53x | 24.85x |
| 2022 | $3.16 Billion | $4.44 Billion | $93.00 Million | 0.71x | 33.95x |
| 2023 | $3.73 Billion | $4.78 Billion | $168.00 Million | 0.78x | 22.21x |
| 2024 | $3.69 Billion | $5.39 Billion | $235.00 Million | 0.68x | 15.70x |
| 2025 | $3.12 Billion | $6.04 Billion | $609.00 Million | 0.52x | 5.13x |
Competitor Companies of AMBU-B by Market Capitalization
Companies near Ambu A/S in the global market cap rankings as of September 16, 2026. Review AMBU-B tangible net assets ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Ambu A/S by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #126 globally with a market cap of $179.26 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #230 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #231 globally with a market cap of $108.12 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #242 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #126 | Abbott Laboratories | NYSE:ABT | $179.26 Billion | $103.09 |
| #230 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $93.80 |
| #231 | Stryker Corporation | NYSE:SYK | $108.12 Billion | $281.87 |
| #242 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Ambu A/S Historical Marketcap From 2015 to 2026
Between 2015 and today, Ambu A/S's market cap moved from $1.46 Billion to $ 2.35 Billion, with a yearly change of 5.18%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Dkr2.35 Billion | -24.66% |
| 2025 | Dkr3.12 Billion | -15.38% |
| 2024 | Dkr3.69 Billion | -1.14% |
| 2023 | Dkr3.73 Billion | +18.20% |
| 2022 | Dkr3.16 Billion | -48.55% |
| 2021 | Dkr6.14 Billion | -34.16% |
| 2020 | Dkr9.32 Billion | +135.96% |
| 2019 | Dkr3.95 Billion | -28.42% |
| 2018 | Dkr5.52 Billion | +41.19% |
| 2017 | Dkr3.91 Billion | +96.82% |
| 2016 | Dkr1.99 Billion | +36.07% |
| 2015 | Dkr1.46 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 15th, 2026 the market cap of Ambu A/S was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.39 Billion USD |
| MoneyControl | $2.39 Billion USD |
| MarketWatch | $2.39 Billion USD |
| marketcap.company | $2.39 Billion USD |
| Reuters | $2.39 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Ambu A/S
Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. The company offers endoscopy products, including bronchoscopes, video laryngoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, ureteroscopes, and displaying and processing units; neurology products, such as… Read more